Literature DB >> 24906824

Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease.

Luis Velázquez-Pérez1, Roberto Rodríguez-Labrada, Edilia M Cruz-Rivas, Juan Fernández-Ruiz, Israel Vaca-Palomares, Jandy Lilia-Campins, Bulmaro Cisneros, Arnoy Peña-Acosta, Yaimeé Vázquez-Mojena, Rosalinda Diaz, Jonathan J Magaña-Aguirre, Tania Cruz-Mariño, Annelié Estupiñán-Rodríguez, José M Laffita-Mesa, Rigoberto González-Piña, Nalia Canales-Ochoa, Yanetza González-Zaldivar.   

Abstract

The prodromal phase of spinocerebellar ataxias (SCAs) has not been systematically studied. Main findings come from a homogeneous SCA type 2 (SCA2) population living in Cuba. The aim of this study was to characterize extensively the prodromal phase of SCA2 by several approaches. Thirty-seven non-ataxic SCA2 mutation carriers and its age- and sex-matched controls underwent clinical assessments, including standardized neurological exam, structured interviews and clinical scales, and looking for somatic and autonomic features, as well as a neuropsychological battery, antisaccadic recordings, and MRI scans. Main clinical somatic features of non-ataxic mutation carriers were cramps, sensory symptoms, sleep disorders, and hyperreflexia, whereas predominating autonomic symptoms were pollakiuria/nocturia, constipation, and frequent throat clearing. Cognitive impairments included early deficits of executive functions and visual memory, suggesting the involvement of cerebro-cerebellar-cerebral loops and/or reduced cholinergic basal forebrain input to the cortex. Antisaccadic task revealed impaired oculomotor inhibitory control but preserved ability for error correction. Cognitive and antisaccadic deficits were higher as carriers were closer to the estimated onset of ataxia, whereas higher Scale for the Assessment and Rating of Ataxia (SARA) scores were associated most notably to vermis atrophy. The recognition of early features of SCA2 offers novel insights into the prodromal phase and physiopathological base of the disease, allowing the assessment of its progression and the efficacy of treatments, in particular at early phases when therapeutical options should be most effective.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906824     DOI: 10.1007/s12311-014-0574-3

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  46 in total

1.  Motor nerve hyperexcitability and muscle cramps in Machado-Joseph disease.

Authors:  Kazuaki Kanai; Satoshi Kuwabara
Journal:  Arch Neurol       Date:  2009-01

2.  The effect of categorization on verbal memory after temporal lobectomy.

Authors:  S Channon; I Daum; C E Polkey
Journal:  Neuropsychologia       Date:  1989       Impact factor: 3.139

3.  Involvement of the cranial nerves and their nuclei in spinocerebellar ataxia type 2 (SCA2).

Authors:  K Gierga; K Bürk; M Bauer; G Orozco Diaz; G Auburger; C Schultz; M Vuksic; L Schöls; R A I de Vos; H Braak; T Deller; U Rüb
Journal:  Acta Neuropathol       Date:  2005-05-19       Impact factor: 17.088

4.  Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7.

Authors:  U Rüb; E R Brunt; E Petrasch-Parwez; L Schöls; D Theegarten; G Auburger; K Seidel; C Schultz; K Gierga; H Paulson; C van Broeckhoven; T Deller; R A I de Vos
Journal:  Neuropathol Appl Neurobiol       Date:  2006-12       Impact factor: 8.090

5.  The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from.

Authors:  T Cruz-Mariño; L Velázquez-Pérez; Y González-Zaldivar; R Aguilera-Rodríguez; M Velázquez-Santos; Y Vázquez-Mojena; A Estupiñán-Rodríguez; J M Laffita-Mesa; R Reynaldo-Armiñán; L E Almaguer-Mederos; M Paneque
Journal:  Clin Genet       Date:  2013-06       Impact factor: 4.438

6.  Heart rate variability in type 2 spinocerebellar ataxia.

Authors:  J Montes-Brown; G Sánchez-Cruz; A M García; M E Báez; L Velázquez-Pérez
Journal:  Acta Neurol Scand       Date:  2010-11       Impact factor: 3.209

7.  Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2.

Authors:  L Velázquez-Pérez; C Seifried; M Abele; F Wirjatijasa; R Rodríguez-Labrada; N Santos-Falcón; G Sánchez-Cruz; L Almaguer-Mederos; R Tejeda; N Canales-Ochoa; M Fetter; U Ziemann; T Klockgether; J Medrano-Montero; J Rodríguez-Díaz; J M Laffita-Mesa; G Auburger
Journal:  Clin Neurophysiol       Date:  2009-02-07       Impact factor: 3.708

8.  Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.

Authors:  Heike Jacobi; Kathrin Reetz; Sophie Tezenas du Montcel; Peter Bauer; Caterina Mariotti; Lorenzo Nanetti; Maria Rakowicz; Anna Sulek; Alexandra Durr; Perrine Charles; Alessandro Filla; Antonella Antenora; Ludger Schöls; Julia Schicks; Jon Infante; Jun-Suk Kang; Dagmar Timmann; Roberto Di Fabio; Marcella Masciullo; Laszlo Baliko; Bela Melegh; Sylvia Boesch; Katrin Bürk; Annkathrin Peltz; Jörg B Schulz; Isabelle Dufaure-Garé; Thomas Klockgether
Journal:  Lancet Neurol       Date:  2013-05-22       Impact factor: 44.182

9.  INECO Frontal Screening (IFS): a brief, sensitive, and specific tool to assess executive functions in dementia.

Authors:  Teresa Torralva; María Roca; Ezequiel Gleichgerrcht; Pablo López; Facundo Manes
Journal:  J Int Neuropsychol Soc       Date:  2009-07-28       Impact factor: 2.892

Review 10.  The neural control of micturition.

Authors:  Clare J Fowler; Derek Griffiths; William C de Groat
Journal:  Nat Rev Neurosci       Date:  2008-06       Impact factor: 34.870

View more
  16 in total

1.  Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.

Authors:  Luis Velázquez-Pérez; Jacqueline Medrano-Montero; Roberto Rodríguez-Labrada; Nalia Canales-Ochoa; Jandy Campins Alí; Frank J Carrillo Rodes; Tania Rodríguez Graña; María O Hernández Oliver; Raul Aguilera Rodríguez; Yennis Domínguez Barrios; Reydenis Torres Vega; Lissi Flores Angulo; Noharis Y Cordero Navarro; Aldo A Sigler Villanueva; Osiel Gámez Rodríguez; Ilya Sagaró Zambrano; Nayime Y Navas Napóles; Javier García Zacarías; Orlando R Serrano Barrera; María B Ramírez Bautista; Annelié Estupiñán Rodríguez; Leonardo A Guerra Rondón; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Luis E Almaguer Mederos; Alejandro Leyva-Mérida
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847

2.  Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2.

Authors:  Luis Velázquez-Pérez; Johannes Tünnerhoff; Roberto Rodríguez-Labrada; Reidenis Torres-Vega; Paolo Belardinelli; Jacqueline Medrano-Montero; Arnoy Peña-Acosta; Nalia Canales-Ochoa; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Georg Auburger; Ulf Ziemann
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

3.  Postural Instability in Prodromal Spinocerebellar Ataxia Type 2: Insights into Cerebellar Involvement Before Onset of Permanent Ataxia.

Authors:  Luis Velázquez-Pérez; Gilberto Sánchez-Cruz; Roberto Rodríguez-Labrada; Mercedes Velázquez-Manresa; Ricardo Hechavarría-Pupo; Luis E Almaguer-Mederos
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

4.  SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.

Authors:  Tania Cruz-Mariño; Yaimeé Vázquez-Mojena; Luis Velázquez-Pérez; Yanetza González-Zaldívar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Annelié Estupiñán-Rodríguez; José Miguel Laffita-Mesa; Luis E Almaguer-Mederos; Milena Paneque
Journal:  J Community Genet       Date:  2015-04-19

5.  Ophthalmic features of spinocerebellar ataxia type 7.

Authors:  A Campos-Romo; E O Graue-Hernandez; L Pedro-Aguilar; J C Hernandez-Camarena; D Rivera-De la Parra; V Galvez; R Diaz; A Jimenez-Corona; J Fernandez-Ruiz
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

6.  Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; Marcio Luiz Escorcio-Bezerra; Agessandro Abrahão; Marcus Vinicius Cristino de Albuquerque; Flavio Moura Rezende Filho; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

7.  Computational neurobiology is a useful tool in translational neurology: the example of ataxia.

Authors:  Sherry-Ann Brown; Louise D McCullough; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

8.  Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.

Authors:  Kathrin Reetz; Roberto Rodríguez-Labrada; Imis Dogan; Shahram Mirzazade; Sandro Romanzetti; Jörg B Schulz; Edilia M Cruz-Rivas; Jose A Alvarez-Cuesta; Raul Aguilera Rodríguez; Yanetza Gonzalez Zaldivar; Georg Auburger; Luis Velázquez-Pérez
Journal:  Ann Clin Transl Neurol       Date:  2018-01-07       Impact factor: 4.511

9.  Autonomic function testing in spinocerebellar ataxia type 2.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean Pierre Ndayisaba; Wolfgang Nachbauer; Roberta Granata; Julia Wanschitz; Michaela Wagner; Elke R Gizewski; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  Clin Auton Res       Date:  2018-02-12       Impact factor: 4.435

Review 10.  The Multiple Faces of Spinocerebellar Ataxia type 2.

Authors:  Antonella Antenora; Carlo Rinaldi; Alessandro Roca; Chiara Pane; Maria Lieto; Francesco Saccà; Silvio Peluso; Giuseppe De Michele; Alessandro Filla
Journal:  Ann Clin Transl Neurol       Date:  2017-08-10       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.